Announcement on Voluntary Disclosure of the FDA Approval of Clinical Trial Application for JS212

About this update from Shanghai Junshi Biosciences Co., Ltd. Class A

Announcement on Voluntary Disclosure of the FDA Approval of Clinical Trial Application for JS212 The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Shanghai Junshi Biosciences Co., Ltd. Class A